Balyasny Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-55,000
Closed -$5.74M 2569
2017
Q4
$5.74M Buy
+55,000
New +$6.21M 0.02% 811
2017
Q1
Sell
-79,800
Closed -$9.24M 1918
2016
Q4
$9.24M Buy
+79,800
New +$8.89M 0.05% 504
2016
Q3
Sell
-325,000
Closed -$32.1M 1471
2016
Q2
$32.1M Buy
+325,000
New +$33.6M 0.21% 130

Other funds holding CELG

Balyasny Asset Management's CELG Position: Q4 2019 in Review

Balyasny Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 993,429 shares — an estimated $98.6M sold.

Balyasny Asset Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $98.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Balyasny Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Balyasny Asset Management sold 993,429 Celgene Corp shares in Q4 2019, an estimated $98.6M.
  • Balyasny Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Balyasny Asset Management's Celgene Corp position peaked at $98.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Balyasny Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.